Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Non-invasive Aesthetic Treatment Market, by End-use
1.4.2 LAMEA Non-invasive Aesthetic Treatment Market, by Procedure
1.4.3 LAMEA Non-invasive Aesthetic Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Product Launches and Product Expansions
3.2.2 Acquisition and Mergers
3.2.3 Partnerships, Collaborations and Agreements
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Sep – 2022, Feb) Leading Players
Chapter 4. LAMEA Non-invasive Aesthetic Treatment Market by End-use
4.1 LAMEA MedSpa Market by Country
4.2 LAMEA Hospital/Surgery Center Market by Country
4.3 LAMEA Traditional Spa Market by Country
4.4 LAMEA HCP Owned Clinic Market by Country
Chapter 5. LAMEA Non-invasive Aesthetic Treatment Market by Procedure
5.1 LAMEA Injectables Market by Country
5.2 LAMEA Skin Rejuvenation Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Non-invasive Aesthetic Treatment Market by Country
6.1 Brazil Non-invasive Aesthetic Treatment Market
6.1.1 Brazil Non-invasive Aesthetic Treatment Market by End-use
6.1.2 Brazil Non-invasive Aesthetic Treatment Market by Procedure
6.2 Argentina Non-invasive Aesthetic Treatment Market
6.2.1 Argentina Non-invasive Aesthetic Treatment Market by End-use
6.2.2 Argentina Non-invasive Aesthetic Treatment Market by Procedure
6.3 UAE Non-invasive Aesthetic Treatment Market
6.3.1 UAE Non-invasive Aesthetic Treatment Market by End-use
6.3.2 UAE Non-invasive Aesthetic Treatment Market by Procedure
6.4 Saudi Arabia Non-invasive Aesthetic Treatment Market
6.4.1 Saudi Arabia Non-invasive Aesthetic Treatment Market by End-use
6.4.2 Saudi Arabia Non-invasive Aesthetic Treatment Market by Procedure
6.5 South Africa Non-invasive Aesthetic Treatment Market
6.5.1 South Africa Non-invasive Aesthetic Treatment Market by End-use
6.5.2 South Africa Non-invasive Aesthetic Treatment Market by Procedure
6.6 Nigeria Non-invasive Aesthetic Treatment Market
6.6.1 Nigeria Non-invasive Aesthetic Treatment Market by End-use
6.6.2 Nigeria Non-invasive Aesthetic Treatment Market by Procedure
6.7 Rest of LAMEA Non-invasive Aesthetic Treatment Market
6.7.1 Rest of LAMEA Non-invasive Aesthetic Treatment Market by End-use
6.7.2 Rest of LAMEA Non-invasive Aesthetic Treatment Market by Procedure
Chapter 7. Company Profiles
7.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Approvals and Agreements:
7.1.5.3 Acquisitions and Mergers:
7.1.5.4 Partnerships, Collaborations and Agreements:
7.2 Allergan PLC (AbbVie)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisitions and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.2.5.3 Approvals and Trials:
7.3 Galderma S.A.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations and Agreements:
7.4 Merz Pharma GmbH & Co. KGaA
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Product Launches and Product Expansions:
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental &Regional Analysis
7.5.4 Research & Development Expenses
7.6 Candela Medical Corporation
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisitions and Mergers:
7.6.2.2 Partnerships, Collaborations and Agreements:
7.7 Bausch Health Companies, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Cutera, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Product Launches and Product Expansions:
7.9 Lumenis Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product Launches and Product Expansions:
7.10. Hologic, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisitions and Mergers:
7.10.5.2 Product Launches and Product Expansions:
Unique Offerings 
